Gene Networks Implicated in Autism, ADHD, Schizophrenia
the Psychiatry Advisor take:
An analysis of DNA from thousands of patients might offer new targets for developing drugs for autism and other neurological disorders, including attention-deficit/hyperactivity disorder and schizophrenia.
The study, published in Nature Communications, compared more than 6,700 patients with autism to 12,500 control subjects and identified three gene families that play functional roles in the disorder -- the CALM1 network, the MXD-MYC-MAX gene network, and the GRM gene family.
The research team is planning a clinical trial in selected ADHD patients of a drug that activates the glutamate receptor metabotropic (GRM) pathway.
"If drugs affecting this pathway prove successful in this subset of patients with ADHD, we may then test these drugs in autism patients with similar gene variants," said study researcher Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at the Children's Hospital of Philadelphia.
Identification of new gene involved in Parkinson's disease may result in new treatments
A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism, attention-deficit/hyperactivity disorder and schizophrenia.
"Neurodevelopmental disorders are extremely heterogeneous, both clinically and genetically," said study leader Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at The Children's Hospital of Philadelphia (CHOP).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders